Pfizer's RSV vaccine shows benefit in immuno-compromised adults in study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 flat as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.42 +0.02 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.40 | 52 Week High | $37.39 | |||
| Open | $28.61 | 52 Week Low | $28.25 | |||
| Day High | $28.61 | P/E | 17.22 | |||
| Day Low | $28.13 | EPS | $1.65 | |||
| Volume | 15,484,686 | |||||
